货号:GS40800
Vonlerolizumab (PF-04518600) is an investigational humanized monoclonal antibody that targets and acts as an agonist of the co-stimulatory receptor OX40 (CD134). It is designed for cancer immunotherapy, with the goal of enhancing anti-tumor immune responses by directly activating OX40-positive T cells, thereby promoting their proliferation, survival, and effector function.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯